What Medicare Claims Tell Us About Cancer Disparities in American Indian and Alaska Native Peoples

• by Cole Allick, Denise A. Dillard

• October 7, 2026

Personalized Cancer Vaccine Linked to Three-Year Disease-Free Survival in Head and Neck Cancer

All 16 patients who received TG4050 after standard treatment remained disease-free, compared with 13 of 16 patients in the control group

• September 16, 2026

• 2 min

Quantitative stability of MGMT promoter methylation in recurrent glioma and implications for temozolomide rechallenge

• by Henry Noren, Gabriella Pelofsky, Brianna Suffren, Laura Mittelman, Christine Yohn, Aminah Twyman, Christopher A. Febres-Aldana, Arevik Abramyan, Aparna Sertil, Randy S. D’Amico, Jonathan H. Sherman, Morana Vojnic

• September 16, 2026

Spinal ependymoma: a comprehensive review of molecular classification, management guidelines, and clinical outcomes with a focus on the pediatric population (Part III of ependymomas across compartments)

• by Anthony M. Price, Nathan S. Fredricks, George Koutsouras, Frederic A. Vallejo, Christopher Bonfield, Devang J. Pastakia, Leo Y. Luo, Frederick Boop, Vijay Ramaswamy, Michael C. Dewan

• October 6, 2026